» Articles » PMID: 25829955

Diagnosis and Therapeutic Options for Peripheral Vasculitic Neuropathy

Overview
Date 2015 Apr 2
PMID 25829955
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Vasculitis can affect the peripheral nervous system alone (nonsystemic vasculitic neuropathy) or can be a part of primary or secondary systemic vasculitis. In cases of pre-existing systemic vasculitis, the diagnosis can easily be made, whereas suspected vasculitic neuropathy as initial or only manifestation of vasculitis requires careful clinical, neurophysiological, laboratory and histopathological workout. The typical clinical syndrome is mononeuropathia multiplex or asymmetric neuropathy, but distal-symmetric neuropathy can frequently be seen. Standard treatments include steroids, azathioprine, methotrexate and cyclophosphamide. More recently the B-cell antibody rituximab and intravenous immunoglobulins have shown to be effective in some vasculitic neuropathy types.

Citing Articles

Neurobartonelloses: emerging from obscurity!.

Bush J, Robveille C, Maggi R, Breitschwerdt E Parasit Vectors. 2024; 17(1):416.

PMID: 39369199 PMC: 11452993. DOI: 10.1186/s13071-024-06491-3.


[Peripheral neuroimmunological diseases - Neuropathological insights and clinical perspectives].

Hoffmann S, Holzer M, Preusse C, Ruck T, Ruffer N, Stascheit F Nervenarzt. 2024; 95(10):920-931.

PMID: 39302417 DOI: 10.1007/s00115-024-01725-2.


A Rare Presentation of Non-systemic Vasculitic Neuropathy Mimicking Guillain-Barré Syndrome: A Case Report.

Munagama C, Wathurapatha W, Rajendiran V, Silva S Cureus. 2024; 16(2):e54945.

PMID: 38544597 PMC: 10968341. DOI: 10.7759/cureus.54945.


The Spectrum of Extraglandular Manifestations in Primary Sjögren's Syndrome.

Mihai A, Caruntu C, Jurcut C, Blajut F, Casian M, Opris-Belinski D J Pers Med. 2023; 13(6).

PMID: 37373950 PMC: 10305413. DOI: 10.3390/jpm13060961.


Vasculitis presenting as carpal tunnel syndrome: a case report.

Rahbar M, Dolatkhah N J Med Case Rep. 2023; 17(1):84.

PMID: 36872340 PMC: 9987105. DOI: 10.1186/s13256-023-03801-8.


References
1.
Di Ciaula A, Covelli M, Berardino M, Wang D, Lapadula G, Palasciano G . Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol. 2008; 8:7. PMC: 2276219. DOI: 10.1186/1471-230X-8-7. View

2.
Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P . The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011; 90(1):19-27. DOI: 10.1097/MD.0b013e318205a4c6. View

3.
Levy Y, Uziel Y, Zandman G, Rotman P, Amital H, Sherer Y . Response of vasculitic peripheral neuropathy to intravenous immunoglobulin. Ann N Y Acad Sci. 2005; 1051:779-86. DOI: 10.1196/annals.1361.121. View

4.
Schonermarck U, Lamprecht P, Csernok E, Gross W . Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford). 2001; 40(2):178-84. DOI: 10.1093/rheumatology/40.2.178. View

5.
Kissel J, Slivka A, Warmolts J, Mendell J . The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol. 1985; 18(2):251-7. DOI: 10.1002/ana.410180213. View